Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Asia Medical and Agricultural Laboratory and Research Center PCL has an F-score of 5 indicating the company's financial situation is typical for a stable company.
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Piotroski F-Score Explanation
The developer of the system is Joseph D. Piotroski is relatively unknown accounting professor who shuns publicity and rarely gives interviews.
He graduated from the University of Illinois with a B.S. in accounting in 1989, received an M.B.A. from Indiana University in 1994. Five years later, in 1999, after earning a Ph.D. in accounting from the University of Michigan, he became an associate professor of accounting at the University of Chicago.
He wanted to see if he can develop a system (using a simple nine-point scoring system) that can increase the returns of a strategy of investing in low price to book (referred to in the paper as high book to market) value companies.
What he found was something that exceeded his most optimistic expectations.
Buying only those companies that scored highest (8 or 9) on his nine-point scale, or F-Score as he called it, over the 20 year period from 1976 to 1996 led to an average out-performance over the market of 13.4%.
Even more impressive were the results of a strategy of investing in the highest F-Score companies (8 or 9) and shorting companies with the lowest F-Score (0 or 1).
Over the same period from 1976 to 1996 (20 years) this strategy led to an average yearly return of 23%, substantially outperforming the average S&P 500 index return of 15.83% over the same period.
Asia Medical and Agricultural Laboratory and Research Center PCL Piotroski F-Score Related Terms
Asia Medical and Agricultural Laboratory and Research Center PCL Piotroski F-Score Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Asia Medical and Agricultural Laboratory and Research Center PCL Piotroski F-Score Chart
Asia Medical and Agricultural Laboratory and Research Center PCL Annual Data
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Asia Medical and Agricultural Laboratory and Research Center PCL Piotroski F-Score vs Hardware Industry
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
*Note: If the latest quarterly/semi-annual/annual total assets data is 0, then we will use previous quarterly/semi-annual/annual data for all the items in the balance sheet.
Profitability
Question 1. Return on Assets (ROA)
Net income before extraordinary items for the year divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Asia Medical and Agricultural Laboratory and Research Center PCL's current Net Income (TTM) was 127.1.
==> Positive ==> Score 1.
Question 2. Cash Flow Return on Assets (CFROA)
Net cash flow from operating activities (operating cash flow) divided by Total Assets at the beginning of the year.
Score 1 if positive, 0 if negative.
Asia Medical and Agricultural Laboratory and Research Center PCL's current Cash Flow from Operations (TTM) was 144.6.
==> Positive ==> Score 1.
Question 3. Change in Return on Assets
Compare this year's return on assets (1) to last year's return on assets.
Asia Medical and Agricultural Laboratory and Research Center PCL's return on assets of this year was 0.16971928. Asia Medical and Agricultural Laboratory and Research Center PCL's return on assets of last year was 0.20093336.
==> Last year is higher ==> Score 0.
Question 4. Quality of Earnings (Accrual)
Compare Cash flow return on assets (2) to return on assets (1)
Asia Medical and Agricultural Laboratory and Research Center PCL's gearing of this year was 0.012548. Asia Medical and Agricultural Laboratory and Research Center PCL's gearing of last year was 0.0191764.
==> This year is lower or equal to last year. ==> Score 1.
Question 6. Change in Working Capital (Liquidity)
Compare this year's current ratio (current assets divided by current liabilities) to last year's current ratio.
Score 1 if this year's current ratio is higher, 0 if it's lower
Asia Medical and Agricultural Laboratory and Research Center PCL's current ratio of this year was 2.48502749. Asia Medical and Agricultural Laboratory and Research Center PCL's current ratio of last year was 3.26665697.
==> Last year's current ratio is higher ==> Score 0.
Question 7. Change in Shares in Issue
Compare the number of shares in issue this year, to the number in issue last year.
Score 0 if there is larger number of shares in issue this year, 1 otherwise.
Asia Medical and Agricultural Laboratory and Research Center PCL's number of shares in issue this year was 414.004. Asia Medical and Agricultural Laboratory and Research Center PCL's number of shares in issue last year was 420.
==> There is smaller number of shares in issue this year, or the same. ==> Score 1.
Efficiency
Question 8. Change in Gross Margin
Compare this year's gross margin (Gross Profit divided by sales) to last year's.
Score 1 if this year's gross margin is higher, 0 if it's lower.
Asia Medical and Agricultural Laboratory and Research Center PCL's gross margin of this year was 0.50268025. Asia Medical and Agricultural Laboratory and Research Center PCL's gross margin of last year was 0.51078586.
==> Last year's gross margin is higher ==> Score 0.
Question 9. Change in asset turnover
Compare this year's asset turnover (total sales for the year divided by total assets at the beginning of the year) to last year's asset turnover ratio.
Score 1 if this year's asset turnover ratio is higher, 0 if it's lower
Asia Medical and Agricultural Laboratory and Research Center PCL's asset turnover of this year was 0.61758677. Asia Medical and Agricultural Laboratory and Research Center PCL's asset turnover of last year was 0.72167122.
==> Last year's asset turnover is higher ==> Score 0.
Evaluation
Piotroski F-Score
=
Que. 1
+
Que. 2
+
Que. 3
+
Que. 4
+
Que. 5
+
Que. 6
+
Que. 7
+
Que. 8
+
Que. 9
=
1
+
1
+
0
+
1
+
1
+
0
+
1
+
0
+
0
=
5
Good or high score = 7, 8, 9
Bad or low score = 0, 1, 2, 3
Asia Medical and Agricultural Laboratory and Research Center PCL has an F-score of 5 indicating the company's financial situation is typical for a stable company.
Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) has a Piotroski F-Score of 5 as of Aug. 23, 2026. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. This is 44% below median its historical median of 9.00. Over the past decade, Asia Medical and Agricultural Laboratory and Research Center PCL's Piotroski F-Score has ranged from 5.00 to 9.00. According to the industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #999 out of 2424 companies in the Hardware industry, placing it in the top 41.2%.
Is Asia Medical and Agricultural Laboratory and Research Center PCL's Piotroski F-Score too high?
Asia Medical and Agricultural Laboratory and Research Center PCL's current Piotroski F-Score of 5 is 44% below median its 10-year median of 9.00. Over the past 10 years, this metric has ranged from a low of 5.00 to a high of 9.00. The Hardware industry median Piotroski F-Score is 5.00. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 5 is 0% at this industry median. Based on the distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #999 out of 2424 companies in the Hardware industry, which is above the industry midpoint. Overall, Asia Medical and Agricultural Laboratory and Research Center PCL has a GF Score™ of 82/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Asia Medical and Agricultural Laboratory and Research Center PCL's Piotroski F-Score compare to COHR and KEYS?
According to the Hardware industry distribution chart, Asia Medical and Agricultural Laboratory and Research Center PCL ranks #999 out of 2424 companies for Piotroski F-Score. This puts Asia Medical and Agricultural Laboratory and Research Center PCL in the upper half of its industry. The industry median Piotroski F-Score is 5.00. Asia Medical and Agricultural Laboratory and Research Center PCL's value of 5 is 0% at this benchmark. Historically, Asia Medical and Agricultural Laboratory and Research Center PCL's own Piotroski F-Score has ranged from 5.00 to 9.00 over the past decade. While the company's 10-year median is 9.00 vs. the industry median of 5.00, Asia Medical and Agricultural Laboratory and Research Center PCL has consistently been at the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Piotroski F-Score for a Hardware company?
The median Piotroski F-Score among Hardware companies is 5.00, based on 2,424 companies in the industry. Companies in the top quartile (top 25%) have a Piotroski F-Score significantly above this median, while those in the bottom quartile fall well below. However, Piotroski F-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Asia Medical and Agricultural Laboratory and Research Center PCL's current Piotroski F-Score of 5 is 0% at the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Piotroski F-Score mean?
A high Piotroski F-Score can signal that a stock is expensive relative to its fundamentals. The Piotroski F-score grades a company's business operating strength from 0-9. View historical data on Asia Medical and Agricultural Laboratory and Research Center PCL and its competitors. For the Hardware industry, the median Piotroski F-Score is 5.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Asia Medical and Agricultural Laboratory and Research Center PCL's current Piotroski F-Score is 5, which is 44% below median its own 10-year median of 9.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Asia Medical and Agricultural Laboratory and Research Center PCL stock overvalued right now?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) is currently considered Significantly Overvalued. The stock's GF Value™ is ฿2.36, compared to a current price of ฿3.18 — trading 34.7% above its estimated fair value. The current Piotroski F-Score is 5, which is 44% below median its 10-year median of 9.00 and 0% at the Hardware industry median of 5.00. Asia Medical and Agricultural Laboratory and Research Center PCL's overall GF Score™ is 82/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Piotroski F-Score calculated?
Piotroski F-Score is calculated from a company's financial statements. For Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC), the current Piotroski F-Score is 5 as of Aug. 23, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Asia Medical and Agricultural Laboratory and Research Center PCL (BKK:AMARC) Overvalued in 2026?
Based on GuruFocus' analysis, Asia Medical and Agricultural Laboratory and Research Center PCL stock appears to be overvalued.
The current stock price of ฿3.18 is trading 34.7% above its estimated GF Value™ of ฿2.36.
GuruFocus considers Asia Medical and Agricultural Laboratory and Research Center PCL to be Significantly Overvalued.
Key valuation signals for BKK:AMARC:
Piotroski F-Score: 5 (44% below median its 10-year median of 9.00)
GF Value™: ฿2.36 vs. price of ฿3.18 (34.7% above fair value)
Industry Position: 0% at the Hardware median (#999 of 2424)
No single metric tells the full story. See the BKK:AMARC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Asia Medical and Agricultural Laboratory and Research Center PCL is engaged in providing comprehensive scientific services for the agriculture, food, pharmaceutical and environment sectors including testing, calibration, inspection and certification according to international quality standards. The company geographically operates only in Thailand.
82GF Score
Get the complete analysis for BKK:AMARC
Piotroski F-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BKK:AMARC has been successfully added to your 
